Form 6-K ARGENX SE For: Dec 20

Go back to Form 6-K ARGENX SE For: Dec 20

argenx SE (ARGX) Defended at Stifel

December 20, 2023 6:17 AM EST

Stifel analyst Derek Archilia reiterated a Buy rating and $560.00 price target on argenx SE (NASDAQ: ARGX)

The analyst comments "The failure of efgartigimod in Pemphigus comes as quite a surprise to us. Even on the heels of the recent failure in ITP, we... More